Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Molecular Residual Disease and Liquid Biopsy Solutions Launched by Labcorp

to deliver ctDNA detection down to a limit of detection (LOD95) of 0.005%. Results are available approximately 14 days after Labcorp receives the initial sample, and seven days for subsequent monitoring time points for each patient. Labcorp Plasma...

OncoIncytes Launched by 1Cell.Ai (Previously OneCell Diagnostics) to Integrate Multi-Modal Data for Precision Oncology

Tumor DNA (ctDNA), Circulating Tumor Cells (CTCs) at single cell resolution, RNA transcriptomics and Proteomics (150 proteins at the single cell level). Marking its evolution from a genomics-based diagnostic company to an AI-powered leader in...

AI Utilized by TNF Pharmaceuticals and Renova Health to Accelerate Drug Development

to identify high-risk patient groups that may benefit the most from interventions that preserve lean muscle mass during GLP-1 treatment for diabetes, weight loss, and chronic weight management. In keeping with FDA’s recent draft Guidance on using...

BioClear Toenail Fungus Device Under Review: Effective LED Laser for Healthy Nails & Discoloration Treatment

and Ages: Unlike harsh antifungal creams or oral medications, the BioClear device uses UV-free light wavelengths, making it 100% safe for daily use without the risk of burns, irritation, or skin damage. There are no known side effects, and the...

ENHERTU® Plus Pertuzumab Significantly Improves Progression-Free Survival vs. THP in 1st-Line Treatment for HER2+ Metastatic Breast Cancer

meaningful improvement in progression-free survival (PFS) compared to a taxane, trastuzumab and pertuzumab (THP) as a 1st-line treatment for patients with HER2-positive metastatic breast cancer. The PFS improvement was seen across all pre-specified...

Paragonix Celebrates a Major Milestone: 100 Kidney Transplants Powered by the FDA-Cleared KidneyVault™ System

FDA clearance in late 2024 and has been rapidly adopted by likeminded organizations across the nation ever since. Now, over 12 OPOs stock the device, and 100 donor kidneys have been placed in a KidneyVault for transplant. This rapid adoption...

HighField Biopharmaceuticals Files INDs for Two ADCplex™ Immunoliposomes with Distinct Payloads to Address Limitations of Current ADCs

to treat cancer and other diseases, announced today it has filed two investigational new drug (IND) applications (HF158K1 and HFK2) with China’s National Medical Products Administration for immunoliposomes carrying different cancer killing...

VCU Collaboration Launched by Galmed Pharmaceuticals to Address Drug Resistance in GI Cancers

mortality worldwide, and treatment options are often limited by therapy resistance. By targeting Stearoyl-CoA Desaturase 1 (SCD1) – a key enzyme in fatty acid metabolism implicated in cancer progression – Aramchol offers a novel therapeutic...

To Revolutionize Coronary Artery Bypass Surgery, AMT Medical Secures $25 Million in Series B Funding

we’re not just improving outcomes – we’re redefining cardiovascular care.” About AMT Medical: AMT Medical (est. 2017) is an Ede and Utrecht-based innovator spun out of neurovascular ELANA technology which was earlier brought to the market (CE and...

Bruker Introduces nVista 2P Miniature Microscope

“It significantly advances our ability to address compelling scientific questions. Having previously relied on the Inscopix 1P miniscope, we have experienced a seamless transition to the 2P miniscope, further amplifying its value as a powerful tool...

JelloX Biotech Establishes U.S. Research Base

pathology, is announcing it will open a lab in the Discovery Oasis biotechnology space in Phoenix, Arizona. An expansive 120-acre development, Discovery Oasis is envisioned as a biotechnology corridor of collaboration to advance groundbreaking...

CollPlant's Collink.3D® BioInks and Technologies Provide a Timely Alternative to Animal Testing in Line with FDA's New Preclinical Guidelines

These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. In 2021, CollPlant entered into a development and global commercialization agreement for dermal and soft tissue fillers with Allergan,...

AdvanCell Proudly Announces $18M in MRFF Frontiers Initiative Funding to Advance Targeted Alpha Therapy for Defeating Prostate Cancer

AdvanCell, a clinical-stage radiopharmaceutical company developing innovative cancer therapeutics, announced $18M in Australian Federal Government Funding from the Medical Research Future Fund (MRFF) Frontiers Initiative for ‘Defeating Prostate...

Exicure, Inc. (Nasdaq: XCUR) Unveils Next Steps Toward New Clinical Trial in Acute Myeloid Leukemia (AML)

Exicure, Inc. today shared updates on its lead asset, GPC-100 (burixafor), a small molecule CXCR4 inhibitor. Exicure, Inc. (“Exicure”) is planning for a clinical trial in Acute Myeloid Leukemia (AML) with GPC-100. The company believes that...

Biologic Therapy Improves Pregnancy Outcomes in High-Risk Antiphospholipid Syndrome Patients, Says HSS

serious adverse outcomes in pregnant women with APS and their babies. The study results were published online on April 10, 2025 in Annals of the Rheumatic Diseases. “The IMPACT study represents a bold and very successful partnership over many years...

Novotech receives new investment from GIC, Temasek, and existing investor TPG to accelerate global growth

positioned to continue its growth in the Asia Pacific region, where demand for clinical trials is forecasted to grow at 15% a year, in addition to focused expansion in the US and Europe. “Novotech is already on its way to be a major global player...

Pykus Therapeutics completes trial enrollment for PYK-2101, a novel retinal sealant for the treatment of retinal detachment

Pykus Therapeutics, Inc. ("Pykus" or the "Company") announced that it has completed enrollment of its pilot study (PYK-2101-RD001) in Australia. The study is evaluating the use of Pykus' proprietary, lead product candidate, PYK-2101, a focal...

IFF Pharma Solutions launches METHOCEL™ HPMC with low nitrite content to mitigate nitrosamine risks

IFF Pharma Solutions, a global leader in polymer innovations, announced the launch of Low Nitrite METHOCEL™ hydroxypropyl methylcellulose (HPMC), a range of low nitrite cellulose ethers developed to reduce the risk of nitrosamine formation in...

SciTech Development announces the second FDA approval of a Phase 1 A/B IND for ST-001, which now targets the treatment of relapsed/refractory small cell lung cancer, following its previous approval for the treatment of T-cell NHL

that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for "A Phase 1a/b Trial in Relapsed/Refractory Small Cell Lung Cancer (SCLC) to Determine the Safety Profile, Pharmacology, and Maximum...

Connected Pill Box Unveiled by Hello Heart to Radically Improve Medication Adherence

smart in-app integrations to enhance its usability and impact. Key features include: Compact, Intuitive Design: With up to 14 spacious yet travel-friendly compartments and built-in light indicators, Pill Box seamlessly fits into daily routines at...